Chemoresistance: impact of nuclear factor (NF)-kappaB inhibition by small interfering RNA. Commentary re J. Guo et al., Enhanced chemosensitivity to irinotecan by RNA interference-mediated down-regulation of the NF-kappaB p65 subunit. Clin Cancer Res 2004;10:3333-3341.
Veiby
Ole Petter
OP
Department of Molecular and Cellular Oncology, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139, USA.
Read
Margaret A
MA
D000818:Animals; D004249:DNA Damage; D015536:Down-Regulation; D005786:Gene Expression Regulation; D006801:Humans; D008954:Models, Biological; D016328:NF-kappa B / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D034741:RNA, Small Interfering / Q000378:metabolism*
D016328:NF-kappa B; D034741:RNA, Small Interfering